[HTML][HTML] Nanomaterials for antiangiogenic therapies for cancer: a promising tool for personalized medicine

HO Alsaab, AS Al-Hibs, R Alzhrani… - International journal of …, 2021 - mdpi.com
Angiogenesis is one of the hallmarks of cancer. Several studies have shown that vascular
endothelium growth factor (VEGF) plays a leading role in angiogenesis progression …

[HTML][HTML] Targeted molecular imaging probes based on magnetic resonance imaging for hepatocellular carcinoma diagnosis and treatment

D Zhao, J Cao, L Zhang, S Zhang, S Wu - Biosensors, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) is the sixth most commonly malignant tumor and the third
leading cause of cancer-related death in the world, and the early diagnosis and treatment of …

[HTML][HTML] A narrative review of near-infrared fluorescence imaging in hepatectomy for hepatocellular carcinoma

W Zhang, Z Hu, J Tian, C Fang - Annals of Translational Medicine, 2021 - ncbi.nlm.nih.gov
Hepatectomy is a main therapeutic strategy for hepatocellular carcinoma (HCC), which
requires removal of primary and disseminated tumors and maximum preservation of normal …

Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer

L Chen, H Fu, H He, K Lou, Q Li, J Ye… - Molecular …, 2023 - ACS Publications
Integrin α6 has been considered a promising biomarker, is overexpressed in many tumors,
and plays a vital role in tumor formation, recurrence, and metastasis. In this study, we …

[HTML][HTML] It's time to shift the paradigm: translation and clinical application of non-αvβ3 integrin targeting radiopharmaceuticals

S Kossatz, AJ Beer, J Notni - Cancers, 2021 - mdpi.com
Simple Summary Cancer cells often present a different set of proteins on their surface than
normal cells. This also applies to integrins, a class of 24 cell surface receptors which mainly …

[HTML][HTML] Integrin α6-targeted molecular imaging of central nervous system leukemia in mice

W Zhang, Y Li, G Chen, X Yang, J Hu… - … in Bioengineering and …, 2022 - frontiersin.org
Central nervous system leukemia (CNS-L) is caused by leukemic cells infiltrating into the
meninges or brain parenchyma and remains the main reason for disease relapse. Currently …

Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models

XR Ni, YY Zhao, HP Cai, ZH Yu, J Wang… - Journal of Neuro …, 2020 - Springer
Objective Optical molecular imaging technology that indiscriminately detects intracranial
glioblastoma (GBM) can help neurosurgeons effectively remove tumor masses. Transferrin …

[HTML][HTML] First-in-human pilot study of an integrin α6-targeted radiotracer for SPECT imaging of breast cancer

S Gao, B Jia, G Feng, C Dong, H Du, L Bai… - Signal transduction and …, 2020 - nature.com
The molecular classification has been playing a crucial role in the precise theranostics of
cancer. Compared with the invasive biopsy, the in vivo noninvasive detection of biomarkers …

An optimized Integrin α6-targeted magnetic resonance probe for molecular imaging of hepatocellular carcinoma in mice

BQ Lin, WB Zhang, J Zhao, XH Zhou, YJ Li… - Journal of …, 2021 - Taylor & Francis
Introduction Integrin α6 is an attractive diagnostic biomarker for molecular imaging of
hepatocellular carcinoma (HCC) as it has an extremely high positive rate (approximately …

An integrin alpha 6-targeted radiotracer with improved receptor binding affinity and tumor uptake

Q Luo, G Yang, H Gao, Y Wang, C Luo… - Bioconjugate …, 2020 - ACS Publications
In this study, we reported a 99mTc-labeled integrin α6-targeted peptide as the molecular
imaging probe for tumor imaging by single-photon emission computed tomography …